According to @CNBC, shares of Eli Lilly (LLY) and Novo Nordisk (NVO) declined after Donald Trump said he wants GLP-1 drugs priced at $150, pressuring the weight-loss and diabetes drug makers on policy headlines. According to @CNBC, the move came on Oct 17, 2025, after the pricing comment, which raised concerns around U.S. drug pricing for GLP-1 therapies. According to @CNBC, there was no reported immediate impact on cryptocurrencies or the broader crypto market.

According to @StockMKTNewz, Prospero’s short-term bull list on Oct 6, 2025 features Eli Lilly LLY, Alibaba BABA, AMD AMD, Baidu BIDU, Meta Platforms META, PayPal PYPL, Amazon AMZN, Novo Nordisk NVO, Microsoft MSFT, and JD.com JD. According to @StockMKTNewz, the post signals a short-term bullish bias for these tickers but does not provide entry levels, stop losses, or a defined time horizon beyond short term. According to @StockMKTNewz, no cryptocurrencies or digital assets are mentioned and the post states no direct implications for BTC, ETH, or the broader crypto market.

According to @business, Novo Nordisk shares rose the most in a month after its diabetes blockbuster Ozempic beat Eli Lilly’s older drug Trulicity in a real-world survey of certain U.S. patients; source: Bloomberg, link: https://www.bloomberg.com/news/articles/2025-09-18/novo-rises-after-ozempic-beats-older-lilly-drug-in-survey. The survey outcome was cited as the catalyst for the session’s move, highlighting trading momentum in Novo Nordisk equity on the comparative effectiveness theme; source: Bloomberg. The report did not cite any direct impact on the cryptocurrency market; source: Bloomberg.

According to @QCompounding, Eli Lilly (LLY) has a 27.1% return on invested capital (ROIC) (source: @QCompounding). @QCompounding states the company is known for treatments in diabetes, cancer, and obesity and is growing fast thanks to new blockbuster drugs, identifying these therapies as the primary growth drivers (source: @QCompounding). The source does not mention any direct impact on the crypto market (source: @QCompounding).